|
|
|
|
|
|
The various shock conditions include: septic shock, systemic inflammatory response syndrome, toxic shock syndrome, adrenal insufficiency, and anaphylaxis. The process of infection by bacteria or fungi can result in systemic signs and symptoms that are variously described. In rough order of serverity, these are bacteremia or fungemia; septicemia; systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis or sepsis syndrome; septic shock; refractory septic shock; multiple-organ dysfunction syndrome, and death. The condition develops as a response to certain microbial molecules which trigger the production and release of cellular mediators, such as tumor necrosis factor (TNF); these act to stimulate immune response. Besides TNFa, other cytokines involved in the development of septic shock include interleukin-1ß, and interferon ?. Healthcare workers considered on individual basis in settings in which high percentage of MDR-TB patients has been found, transmission of MDR-TB is likely, and TB control precautions have been implemented and not successful. BCG vaccine and tuberculin skin test Tuberculin skin testing is not contraindicated for BCG-vaccinated persons. Latent TB infection (LTBI) diagnosis and treatment for LTBI is considered for any BCG-vaccinated person whose skin test is 10 mm or greater, if any of these circumstances are present: Was contact of another person with infectious TB Was born or has resided in a high TB prevalence country Is continually exposed to populations where TB prevalence is high. Tuberculosis vaccine The first recombinant tuberculosis vaccine entered clinical trials in the United States in 2004 sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). Click on following items to see more information: Anaerobic bacterium, Antibiotic, Antibiotic resistance, Antibacterial, Bacilli, Bacillus subtilis, Bacterium, Bacterial, Phages, Baker's yeast, Brevibacterium, C. albicans, Cell suspension, Clostridium, Culture media, E. coli, E. coli, E. coli, E. coli, E. coli, Enterobacter, Fermentation, Yeast, Gram positive, Halomonas, Listeria, Bacterial, Bacterial, Bacterium, Nitrification, Prokaryote, P. aeruginosa, Rhizobacteria, Saccharomyces cerevisiae, Saccharomyces cerevisiae, Salmonella typhimurium, Serratia, S. aureus, Streptococcus, Streptococcus, Vancomycin, Yeast Escherichia coli, better known as E. coli, is one of the most important model organisms and its genetics and biochemistry have been closely studied. Salmonella enterica is a species of Salmonella bacterium. S. enterica has a number of varieties or serovars. Serovar Typhi (sometimes elevated to species status as S. typhi) is the disease agent in typhoid. Other serovars such as Typhimurium (also known as S. typhimurium) can lead to a form of human gastroenteritis sometimes referred to as salmonellosis. Most cases of salmonellosis are caused by food infected with S. enterica, which often infects cattle, though also other animals such as domestic cats. However, investigations of vacuum cleaner bags have shown that households can act as a reservoir of the bacterium; this is more likely if the household has contact with an infection source, for example through members working with cattle or in a veterinary clinic. Bdellovibrio is a genus of Gram-negative, obligate aerobic bacteria. One of the more notable characteristics of this genus is that members parasitize other gram-negative bacteria by entering into their periplasmic space and feeding on the biopolymers, e.g. proteins and nucleic acids, of their hosts. After entering the periplasmic space of its host the Bdellovibrio bacterium forms a structure called bdelloplast, which consists of both predator and prey. The predator cell can remain dormant at this stage, without affecting the viability of the host. In most cases, though, Bdellovibrio moves on and devours its prey.
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||
